Abstract
As many investigators will attest, developing and conducting a research program in the field of mental health is a very difficult task. It is only in the last 20 years that a few hints have appeared in the literature from animal research in the fields of neuropharmacology and neurochemical correlates of behavior that give the researcher any leads on which to base an active clinical-basic research program. These ideas have led to some important clinical studies that will be referred to below. It is interesting that some recent work with animal models of depression has again provided the research clinician with new insights for further experimentation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alpers, H. S., and Himwich, H. E., 1972, The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepinephrine and dopamine, J. Pharmacol. 190:531.
Aprison, M. H., 1965, Research approaches to problems in mental illness. Brain neurohumorenzyme systems and behavior, in: Horizons in Neuropsychopharmacology (W. Himwich and J. Schade, eds.), pp. 48–80, Elsevier, Amsterdam.
Aprison, M. H., and Ferster, C. B., 1960, Behavioral effects of 5-hydroxytryptophan, Experientia 16:159.
Aprison, M. H., and Ferster, C. B., 1961a, Neurochemical correlates of behavior. I. Quantitative measurement of the behavioral effects of the serotonin precursor, 5-hydroxytryptophan, J. Pharmacol. Exp. Ther. 131:100.
Aprison, M. H., and Ferster, C. B., 1961b, Neurochemical correlates of behavior. II. Correlation of brain monoamine oxidase activity with behavioral changes after iproniazid and 5-hydroxytryptophan administtration, J. Neurochem. 6:350.
Aprison, M. H., and Ferster, C. B., 1961c, Serotonin and behavior, in: Recent Advances in Biological Psychiatry, Vol. 3, Chapt. 12, (J. Wortis, ed.), pp. 151–162, Grune and Stratton, New York.
Aprison, M. H., and Hingtgen, J. N., 1965, Neurochemical correlates of behavior. IV. Norepinephrine and dopamine in four brain parts of the pigeon during period of atypical behavior following the injection of 5-hydroxytryptophan, J. Neurochem. 12:959.
Aprison, M. H., and Hingtgen, J. N., 1966a, Neurochemical correlates of behavior. V. Differential drug effects on approach and avoidance behavior in rats with related changes in brain serotonin and norepinephrine, Recent Adv. Biol. Psychiatry 8:87.
Aprison, M. H., and Hingtgen, J. N., 1966b, Neurochemical correlates of behavior. VI. 5-Hydroxytryptamine, norepinephrine, α-methyl-m-tyramines and 3,4-dihydroxyphenyle-thylamine concentrations in pigeon brain during the period of atypical behavior following the injection of α-methyl-meta-tyrosine, Life Sci. 5:1071.
Aprison, M. H., and Hingtgen, J. N., 1970, Neurochemical correlates of behavior, Int. Rev. Neurobiol. 13:325.
Aprison, M. H., and Hingtgen, J. N., 1972, Serotonin and behavior: A brief summary, Fed. Proc. Fed. Am. Soc. Exp. Biol. 31:121.
Aprison, M. H., Wolf, M. A., Poulos, G. L., and Folkerth, T. L., 1962, Neurochemical correlates of behavior. III. Variation of serotonin content in several brain areas and peripheral tissues of the pigeon following 5-hydroxytryptophan administration, J. Neurochem. 9:575.
Aprison, M. H., Hingtgen, J. N., and McBride, W. J., 1975, Serotonergic and cholinergic mechanisms during disruption of approach and avoidance behavior, Fed. Proc. Fed. Am. Soc. Exp. Biol. 34:1813.
Ashcroft, G. W., MacDougall, E. J., and Barker, P. A., 1961, A comparison of tetrabenazine and chlorpromazine in chronic schizophrenia, J. Ment. Sci. 107:287.
Ashcroft, G. W., Crowford, T. B. B., Eccleston, D., Sharman, D. F., McDougall, E. J., Stanton, J. B., and Binns, J. K., 1966, 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases, Lancet 2:1049.
Bein, H. J., 1953, The pharmacology of reserpine, a new alkaloid from Rauwolfia serpentina, Experientia 9:107.
Beskow, J., Gottfries, C. G., Roose, B. E., and Winblad, B., 1976, Determination of monoamine and monoamine metabolites in the human brain: Post mortem studies in a group of suicides and in a control group, Acta Psychiatr. Scand. 53:7.
Bogdanski, D. F., Weissbach, H., and Udenfriend, S., 1957, The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain, J. Neurochem. 1:212.
Bourne, H. R., Bunney, W. E., Colburn, R. W., Davis, J. M., Davis, J. N., Shaw, D. M., and Coppen, A. J., 1968, Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients, Lancet 2:805.
Bowers, M. B., Jr., 1974, Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes, J. Nerv. Ment. Dis. 158:325.
Bowers, M. B., Jr., Henninger, G. R., and Gerbode, F., 1969, Cerebrospinal fluid 5-hydrox-yindoleacetic acid and homovanillic acid in psychiatric patients, Int. J. Neuropharmacol. 8:255.
Brodie, H. K. H., Keith, H., Sack, R., and Siever, L., 1973, Clinical studies of l-5-hydroxytryptophan in depression, in: Serotonin and Behavior (J. Barchas and E. Usdin, eds.), pp. 549–559, Academic Press, New York.
Bruinvels, J., 1972, Inhibition of the biosynthesis of 5-hydroxytryptamine in rat brain by imipramine, Eur. J. Pharmacol. 20:231.
Bunney, W. E., Jr., Brodie, H. K. H., Murphy, D. L., and Goodwin, F. K., 1971, Studies of alpha-methyl-para-tyrosine, L-dopa, and tryptophan in depression and mania, Am. J. Psychiatry 127:872.
Cahn, J., and Herold, M. M., 1960, Etude pharmacologique du Ro 1–9569 (tetrabenazine), Psychiatr. Neurol. Basel 140:210.
Carroll, B. J., Mowbray, R. M., and Davies, B. M., 1970, L-Tryptophan in depression, Lancet 2:776.
Cochran, E. Robins, E., and Grote, S., 1976, Regional serotonin levels in brain: A comparison of depressive suicides and alcoholic suicides with controls, Biol. Psychiatry 11:283.
Coppen, A., 1971, Biogenic amines and affective disorders, Adv. Merit. Sci. 4:123.
Coppen, A., Prange, A. J., Jr., Whybrow, P. C., Noguera, R., and Paez, J. M., 1969, Methyseigide in mania, Lancet 2:338.
Coppen, A., Prange, A. J., Jr., Whybrow, P. C., and Noguera, R., 1972, Abnormalities of indoleamine in affective disorders, Arch. Gen. Psychiatry 26:474.
Corrodi, H., and Fuxe, K., 1969, Decreased turnover in central 5-HT nerve terminals induced by antidepressant drugs of the imipramine type, Eur. J. Pharmacol. 7:56.
Costa, E., 1956, Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions, Proc. Soc. Exp. Biol. (N.Y.) 91:39.
Costa, E., and Aprison, M. H., 1958a, Studies on the 5-hydroxytryptamine (serotonin) content in human brain, J. Nerv. Ment. Dis. 126:289.
Costa, E., and Aprison, M. H., 1958b, Distribution of intracarotidly injected serotonin in brain, Am. J. Physiol. 192:95.
Court, J. H., and Mai, F. M., 1970, A double-blind intensive crossover design trial of methysergide in mania, Med. J. Aust. 2:526.
Cremata, V. Y., Jr., and Koe, B. K., 1966, Clinical-pharmacological evaluation of p-chlorophenylalanine: A new serotonin depleting agent, Clin. Pharmacol. Ther. 7:768.
Dencker, S. J., Malm, U., Roos, B., and Werdinius, B., 1966, Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania, J. Neurochem. 13:1545.
Dolin, A. O., 1951, Uslovnoryeflektornoye katalyeptitseyeskoye sostoyaniye, Pavlov J. Higher Nerv. Act. 1:485.
Engleman, K., Lovenberg, W., and Sjöerdsma, A., 1967, Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome, N. Engl. J. Med. 277:1103.
Ferster, C. B., and Skinner, B. F., 1957, Schedules of Reinforcement, Appleton-Century-Crofts, New York.
Freis, E. D., 1954, Mental depression in hypertensive patients treated for long periods with large doses of reserpine, N. Engl. J. Med. 251:1006.
Gaddum, J. H., 1954, Drugs antagonistic to 5-hydroxytryptamine in: Ciba Found. Symp.: Hypertension, Humoral and Neurogenic Factors, (G. E. W. Wolstenholme, M. P. Cameron, eds.), pp. 75–77, Little, Brown and Co., Boston.
Garven, J. D., 1956, The estimation of 5-hydroxytryptamine in the presence of adrenaline, Br. J. Pharmacol. 11:1.
Gayford, J. J., Parker, A. L., Phillips, E. M., and Rowsell, A. R., 1973, Whole Blood 5-hydroxytryptamine during treatment of endogenous depressive illness, Br. J. Psychiatry 122:597.
Goodwin, F. K., and Post, R. M., 1974, Brain serotonin, affective illness, and antidepressant drugs: Cerebrospinal fluid studies with probenecid, Adv. Biochem. Psychopharmacol. 11:341.
Goodwin, F. K., Post, R. M., Dunner, D. L., and Gordon, E. K., 1973, Cerebrospinal fluid amine metabolites in affective illness: The probenecid technique, Am. J. Psychiatry 130:73.
Gottfries, C. G., Roos, B. E., and Winblad, B., 1974, Determination of monoamines and monoamine metabolites in the human brain post mortem, Psihofarmakologija 3, in: Proceedings of the Third Yugoslavian Psychopharmacological Symposium (M. Mihovi-lovic, ed.), pp. 99–104, Opatija 1973, Medicinska Naklada, Zagreb.
Green, A. R., and Grahame-Smith, D. G., 1976, Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine, Nature (London) 260:487.
Harris, T. H., 1957, Depression induced by Rauwolfia compounds, Am. J. Psychiatry 113:950.
Himwich, H. E., 1971, Biochemistry, Schizophrenias and Affective Illnesses, The Williams and Wilkins Co., Baltimore.
Hingtgen, J. N., and Aprison, M. H., 1963, The effect of alpha-methyl-meta-tyrosine on behavioral response rates in pigeons, Science 141:169.
Hingtgen, J. N., and Aprison, M. H., 1965, Interrelation between four measures of the behavioral response in pigeons with elevated serotonin levels, Recent Adv. Biol. Psychiatry 7:163.
Hingtgen, J. N., and Aprison, M. H., 1966, Food consumption in pigeons following the administration of α-methyl-meta-tyrosine during approach behavior and free feeding, Life Sci. 5:1249.
Hingtgen, J. N., and Aprison, M. H., 1975, Behavioral depression in pigeons following L-tryptophan administration, Life Sci. 16:1471.
Hingtgen, J. N., and Aprison, M. H., 1976, Behavioral and environmental aspects of the cholinergic system, in: Biology of Cholinergic Function (A. M. Goldberg and I. Hanin, eds.), pp. 515–566, Raven Press, New York.
Kline, N., Sacks, W., and Simpson, G. M., 1964, Further studies on one day treatment of depression with 5-HTP, Am. J. Psychol. 12:379.
Leusen, I., Lacroix, E., and Demeester, G., 1959, Quelques proprietes pharmacodynamiques de la tetrabenazine, substance liberatrice de serotonine, Arch. Int. Pharmacodyn. Ther. 119:225.
Lingjaerde, O., 1963, Tetrabenazine (Nitoman) in the treatment of psychoses. With a discussion on the central mode of action of tetrabenazine and reserpine, Acta Psychiatr. Scand. Suppl. 170:1.
Lloyd, K. G., Farley, I. J., Deck, J. H. N., and Hornykiewicz, O., 1974, Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients, Adv. Biochem. Psychopharmacol. 11:387.
Macchitelli, F. J., Fischetti, D., and Montanarelli, N., 1966, Changes in behavior and electrocortical activity in the monkey following administration of 5-hydroxytryptophan (5-HTP), Psychopharmacologia 9:447.
Mandell, A. J., Segal, D. S., Kuczenski, R. T., and Knapp, S., 1972, Some macromolecular mechanisms in CNS neurotransmitter pharmacology and their physiological organizations, in: The Chemistry of Mood, Motivation and Memory (J. McGaugh, ed.), pp. 105–148, Plenum Press, New York.
Matussek, N., Angst, J., Benkert, O., Gmur, M., Papousek, M., Ruther, E., and Woggon, B., 1974, The effect of l-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (RO4–4602) in depressive patients, Adv. Biochem. Psychopharmacol. 11:399.
McBride, W. J., and Aprison, M. H., 1973, Release of 5-hydroxytryptamine from serotonergic nerve endings by α-methyl-meta-tyramine, Pharmacol. Biochem. Behavior 1:587.
McBride, W. J., Aprison, M. H., and Hingtgen, J. N., 1973, Effects of α-methyl-meta-tyrosine, α-methyl-meta-tyramine and metaraminol on the serotonin content in preparations of whole tissue and synaptosomes from the telencephalon of the pigeon, Neuropharmacology 12:769.
McBride, W. J., Aprison, M. H., and Hingtgen, J. N., 1974, Effects of 5-hydroxytryptophan on serotonin in nerve endings, J. Neurochem. 23:385.
McLeod, W. R., and McLeod, M., 1972, Indolamines and cerebrospinal fluid, in: Depressive Illness (B. M. Davies, B. J. Carroll, and R. M. Mowbray, eds.), pp. 209–225, Charles C. Thomas, Springfield, Illinois.
Mendels, J., Stinnett, J. L., Burns, D., and Frazer, A., 1975, Amine precursors and depression, Arch. Gen. Psychiatry 32:22.
Muller, J. C., Pryor, W. W., Gibbons, J. E., and Orgain, E. S., 1955, Depression and anxiety occurring during Rauwolfia therapy, J. Am. Med. Assoc. 159:836.
Murphy, D. L., and Kopin, I. J., 1972, The transport of biogenic amines, in: Metabolic Transport (L. E. Hokin, ed.), pp. 503–542, Academic Press, New York.
Murphy, D. L., Baker, M., Kotin, J., and Bunney, W. E., Jr., 1973, Behavioral and metabolic effects of l-tryptophan in unipolar depressed patients, in: Serotonin and Behavior (J. Barchas and E. Usdin, eds.), pp. 529–537, Academic Press, New York.
Murphy, D. L., Baker, M., Goodwin, F. K., Miller, H., Kotin, J., and Bunney, W., 1974, l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects, Psychopharmacologia 34:11.
Nagayama, H., Kido, A., and Takahashi, R., 1972, Utsubyo no dobutsu modem, Igaku To Seibutsugaku 84:163.
Paasonen, M. K., MacLean, P. D., and Giarman, N. J., 1957, 5-Hydroxytryptamine (serotonin, enteramine) content of structures of the limbic system, J. Neurochem. 1:326.
Papeschi, R., and McClure, D. J., 1971, Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients, Arch. Gen. Psychiatry 25:354.
Pare, C. M. B., Yeung, D. P. H., Price, K., and Stacey, R. S., 1969, 5-Hydroxytryptamine, noradrenaline, and dopamine in caudate nucleus of controls and of patients committing suicide by cool-gas poisoning, Lancet 2:133.
Pletscher, A., 1957, Release of 5-hydroxytryptamine by benzoquinoline derivatives with sedative action, Science 126:507.
Pletscher, A., and Gey, K. F., 1962, Drug-induced alterations of the metabolism of cerebral monoamines, in: Monoamines et système nerveux central (J. de Ajuriaguerra, ed.), pp. 105–115, Georg & Cie SA, Genève.
Pletscher, A., Besendorf, H., and Bächtold, H. P., 1958, Benzo(a)chinolizine, eine neue Körperklasse mit Wirkung auf den 5-Hydroxytryptamine-und Noradrenaline-Stoffwechsel des Gehirns, Arch. Exp. Pathol. Pharmakol. 232:499.
Pletscher, A., Besendorf, H., and Gey, K. F., 1959, Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives, Science 129:844.
Pletscher, A., Brossi, A., and Gey, K. F., 1962, Benzoquinolizine derivative: A new class of monoamine decreasing drugs with psychotropic action, Rev. Neurobiol. 6:275.
van Praag, H. M., 1974, Towards a biochemical typology of depression?, Pharmakopsychiatr. Neuro-Psychopharmakol. 7:281.
van Praag, H. M., and Korf, J., 1971, Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?, Psychopharmacology 19:148.
van Praag, H. M., and Korf, J., 1974, Serotonin metabolism in depression: Clinical application of the probenecid test, Int. Pharmacopsychiatry 9:35.
van Praag, H. M., Korf, J., and Puite, J., 1970, 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid, Nature (London) 225:1259.
van Praag, H. M., Korf, J., and Schut, D., 1973, Cerebral monoamines and depression. An investigation with the probenecid technique, Arch. Gen. Psychiatry 28:827.
Prange, A. J., Jr., Wilson, I. C., Lynn, C. W., Alltop, L. B., and Stikeleather, R. A., 1974, l-Tryptophan in mania. Contribution to a permissive hypothesis of affective disorders, Arch. Gen. Psychiatry 30:56.
Quinn, G. P., Shore, P. A., and Brodie, B. B., 1959, Biochemical and pharmacological studies of RO 1–9569 (tetrabenazine), a non-indole tranquilizing agent with reserpine-like effects, J. Pharmacol. Exp. Ther. 127:103.
Reid, W. D., Stefano, F. J. E., Kurzepa, S., and Brodie, B. B., 1969, Tricyclic antidepressants: Evidence for an intraneuronal site of action, Science 164:437
Sano, I., 1972, L-5-Hydroxytryptophan-therapie, Folia Psychiatr. Neurol. Jpn. 26:7.
Schanberg, S. M., Schildkraut, J. J., and Kopin, I. J., 1967, The effects of psychoactive drugs on norepinephrine-3H metabolism in brain, Biochem. Pharmacol. 16:393.
Schroender, H. A., and Perry, H. M., 1955, Psychosis apparently produced by reserpine, J. Am. Med. Assoc. 159:839.
Shaw, D. M., Camps, F. E., and Eccleston, E. G., 1967, 5-Hydroxytryptamine in the hindbrain of depressive suicides, Br. J. Psychiatry 113:1407.
Shore, P. A., 1962, Release of serotonin and catecholamines by drugs, Pharmacol. Rev. 14:531.
Sjöerdsma, A., Lovenberg, W., Engelman, K., Carpenter, W. T., Jr., Wyatt, R. J., and Gessa, G.L., 1970, Serotonin now: Clinical implications of inhibiting its synthesis with para- chlorophenylalanine, Ann. Intern. Med. 73:607.
Sjöström, R., 1973, 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment, Eur. J. Clin. Pharmacol. 6:75.
Sjöström, R., and Roos, B. E., 1972, 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in manic depressive psychosis, Eur. J. Clin. Pharmacol. 4:170.
Tachiki, K. H., Takagi, A., Tateishi, T., and Takahashi, R., 1974, Utsubyo no dobutsu moderu ni okeru tetrabenazine no sayokijo-III, Bull. Jpn. Neurochem. Soc. 13:29.
Tachiki, K. H., Takagi, A., Tateishi, T., Kido, A., Nishiwaki, K., Nakamura, E., Nagayama, H., and Takahashi, R., 1977, Animal model of depression. III. Mechanisms of action of tetrabenazine, Biol. Psychiatry, in press.
Takahashi, R., 1975, Cerebral amine metabolism in manic-depressive illness-Present status and reconsideration of amine theory, Jpn. J. Clin. Chem. 4:124.
Takahashi, R., Nagayama, H., Kido, A., and Morita, T., 1974, An animal model of depression, Biol. Psychiatry 9:191.
Takahashi, R., Tachiki, K., Nishiwaki, K., Nakamura, E., Tateishi, T., and Nagayama, H., 1975, Biochemical basis of an animal model of depressive illness, Bull. Jpn. Neurochem. Soc. 14:13.
Tateishi, T., Nakamura, E., Nagayama, H., Sakurai, Y., and Takahashi, R., 1973, Tetrabena-zine-moderu ni yoru utsubyo no seikagaku-teki kenkyu-II, Annu. Rep. Pharmacopsy-chiatr. Res. Found., No. 5, p. 82.
Tateishi, T., Tachiki, K. H., Nakamura, E., Takagi, A., and Takahashi, R., 1974, Tetrabena-zine-moderu ni yoru utsubyo no seikagaku-teki kenkyu-III, Annu. Rep. Pharmacopsy-chiatr. Res. Found., No. 6, p. 83.
Tateishi, T., Tachiki, K., Nakamura, E., Takagi, A., Nagayama, H., Sakurai, Y., and Takahashi, R., 1975, Behavioral sedation in animals and associated biochemical changes-study of a model of depression induced by tetrabenazine in rats, Bull. Neuroinformation Laboratory Nagasaki University No. 2:96–105.
Woolley, D. W., and Shaw, E., 1954a, A biochemical and pharmacological suggestion about certain mental disorders, Proc. Natl. Acad. Sci. U.S.A., 40:228.
Woolley, D. W., and Shaw, E., 1954b, Some neurophysiological aspects of serotonin, Br. Med. J. 2:122.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Aprison, M.H., Takahashi, R., Tachiki, K. (1978). Hypersensitive Serotonergic Receptors Involved in Clinical Depression—A Theory. In: Haber, B., Aprison, M.H. (eds) Neuropharmacology and Behavior. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3961-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3961-8_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3963-2
Online ISBN: 978-1-4613-3961-8
eBook Packages: Springer Book Archive